What are the classifications of shock and how are they managed?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: October 21, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Types of Shock and Management

Shock is classified into four major categories—hypovolemic, distributive, cardiogenic, and obstructive—each requiring distinct management strategies, with distributive (septic) shock demanding immediate fluid resuscitation with at least 30 mL/kg crystalloid within 3 hours, norepinephrine as first-line vasopressor targeting MAP ≥65 mmHg, and early antibiotics within 1 hour. 1, 2, 3

Classification of Shock

The four fundamental types of shock correspond to specific organ system failures 3:

1. Hypovolemic Shock

  • Mechanism: Absolute intravascular volume loss
  • Causes: Hemorrhage, severe dehydration, burns
  • Key feature: Decreased preload due to actual fluid loss

2. Distributive Shock

  • Mechanism: Pathological redistribution of blood volume with relative hypovolemia
  • Causes: Sepsis (most common), anaphylaxis, neurogenic causes
  • Key feature: Vasodilation leading to maldistribution of blood flow despite normal or increased cardiac output

3. Cardiogenic Shock

  • Mechanism: Primary cardiac pump failure
  • Causes: Myocardial infarction, severe heart failure, arrhythmias, myocarditis
  • Key feature: Inadequate cardiac output despite adequate preload

4. Obstructive Shock

  • Mechanism: Physical obstruction to circulation
  • Causes: Pulmonary embolism, cardiac tamponade, tension pneumothorax
  • Key feature: Elevated resistance preventing adequate blood flow

Initial Recognition and Assessment

Immediately assess for tissue hypoperfusion using capillary refill time, skin temperature, mottling, and lactate levels 2. The presence of elevated lactate (≥4 mmol/L) or hypotension persisting after initial fluid challenge defines shock requiring aggressive intervention 1.

Critical Assessment Steps:

  • Capillary refill time: >2 seconds indicates poor perfusion 4, 2
  • Lactate measurement: Serial measurements guide resuscitation adequacy 2
  • Hemodynamic variables: Heart rate, blood pressure, urine output, mental status 1
  • Echocardiography: First-line imaging to determine shock type 2

Management by Shock Type

Septic/Distributive Shock Management

This is the most extensively studied shock type with the strongest guideline support:

Immediate Actions (Within 1 Hour):

  1. Obtain blood cultures, then administer broad-spectrum antibiotics within 1 hour 1
  2. Begin aggressive fluid resuscitation immediately 1

Fluid Resuscitation Protocol:

  • Administer at least 30 mL/kg IV crystalloid within first 3 hours (strong recommendation) 1
  • Use isotonic crystalloids (normal saline or balanced solutions) or albumin—no significant outcome difference 4
  • Reassess after every fluid bolus for signs of fluid responsiveness versus overload 4, 2
  • Use dynamic variables (pulse pressure variation, stroke volume variation) over static measures (CVP) to predict fluid responsiveness 1, 2

Common Pitfall: Avoid continuing fluid boluses when hepatomegaly or rales develop—this signals fluid overload requiring vasopressor/inotrope initiation, not more fluids 5.

Vasopressor Management:

  • Norepinephrine is the first-choice vasopressor (strong recommendation) 1
  • Target MAP ≥65 mmHg (strong recommendation) 1
  • Add vasopressin (up to 0.03 U/min) or epinephrine if MAP target not achieved with norepinephrine alone 1
  • Dopamine only for highly selected patients (low tachyarrhythmia risk, bradycardia present) 1
  • Never use low-dose dopamine for renal protection (strong recommendation against) 1

Inotropic Support:

  • Use dobutamine for persistent hypoperfusion despite adequate fluids and vasopressors (indicates low cardiac output state) 1
  • Titrate to perfusion endpoints; discontinue if worsening hypotension or arrhythmias occur 1

Corticosteroids:

  • Do NOT use hydrocortisone if adequate fluid resuscitation and vasopressors restore hemodynamic stability 1
  • If hemodynamic stability NOT achievable, give hydrocortisone 200 mg/day IV 1
  • Taper when vasopressors no longer required 1

Mechanical Ventilation (if ARDS develops):

  • Tidal volume 6 mL/kg predicted body weight (strong recommendation) 1
  • Plateau pressure ≤30 cm H₂O 1
  • Prone positioning for PaO₂/FiO₂ ≤100 mmHg 1

Hypovolemic Shock Management

  • Rapid crystalloid boluses (20 mL/kg) until perfusion improves 6, 3
  • No advantage to colloids over crystalloids in early resuscitation 6
  • For hemorrhagic shock: Control bleeding source, transfuse when Hgb <7 g/dL (target 7-9 g/dL) once hypoperfusion resolved 1
  • Avoid excessive crystalloid in hemorrhage—may worsen coagulopathy 3

Cardiogenic Shock Management

  • Identify and treat underlying cause (MI, arrhythmia, valvular disease) 3, 7
  • Minimize fluid administration—these patients are preload-sensitive but volume-overloaded 3
  • Inotropic support with dobutamine for low cardiac output 3
  • Consider mechanical circulatory support (IABP, Impella, ECMO) for refractory cases 7
  • Vasodilators may be needed if elevated systemic vascular resistance with adequate blood pressure 5

Critical Distinction: Unlike distributive shock, cardiogenic shock worsens with aggressive fluid resuscitation—use echocardiography to differentiate 2, 3.

Obstructive Shock Management

  • Immediate life-saving intervention to remove obstruction 3:
    • Tension pneumothorax: Needle decompression then chest tube
    • Cardiac tamponade: Pericardiocentesis
    • Massive PE: Thrombolysis or embolectomy
  • Rule out in refractory shock: Check for pneumothorax, tamponade, intra-abdominal hypertension >12 mmHg 5

Pediatric Considerations

For children with septic shock 4, 5:

  • Fluid boluses of 10-20 mL/kg with frequent reassessment (reasonable approach) 4
  • Either epinephrine or norepinephrine as initial vasoactive agent (both reasonable) 4
  • Begin peripheral inotropic support until central access obtained 5
  • Consider stress-dose corticosteroids for fluid-refractory shock requiring vasoactive support 4

Monitoring and Reassessment

Essential monitoring parameters 2:

  • Arterial catheter for continuous blood pressure in vasopressor-dependent shock 1, 2
  • Serial lactate measurements to guide resuscitation 1, 2
  • Central venous oxygen saturation (ScvO₂) if central line present—target >70% 5, 6
  • Urine output ≥0.5 mL/kg/hr 1
  • Cardiac output/stroke volume monitoring in non-responders 2

Reassess hemodynamic status after every intervention—clinical examination plus available monitoring data guide next steps 1, 2.

Key Pitfalls to Avoid

  1. Delaying antibiotics in septic shock: Must give within 1 hour 1
  2. Continuing fluids despite signs of overload: Switch to vasopressors/inotropes when rales or hepatomegaly develop 5
  3. Using dopamine for renal protection: No benefit, potential harm 1
  4. Treating all shock with aggressive fluids: Cardiogenic shock worsens with volume 3
  5. Missing obstructive causes: Always evaluate for tamponade, pneumothorax, PE in refractory shock 5
  6. Using etomidate in septic shock: Associated with higher mortality 6

Blood Product Transfusion

  • RBC transfusion threshold <7 g/dL once hypoperfusion resolved (target 7-9 g/dL) 1
  • Exceptions requiring higher threshold: Active bleeding, myocardial ischemia, severe hypoxemia 1
  • Platelet transfusion: <10,000/mm³ prophylactically; <20,000/mm³ if bleeding risk; ≥50,000/mm³ for active bleeding/procedures 1
  • Do NOT use FFP to correct lab abnormalities without bleeding 1

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.